Tuberculosis treatment and cytotoxic immune signatures: a longitudinal study
{{output}}
Background: Tuberculosis (TB) remains a leading cause of global mortality. Current tools for monitoring therapeutic efficacy are suboptimal, creating an urgent need for novel strategies. While emerging evidence suggests that immu... ...